Comparing two drugs to control river blindness and other neglected diseases
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in a village selected for the treatment program
- You can take one of the two study drugs (ivermectin or moxidectin) based on your age and health
- You are not allergic to ivermectin or moxidectin
- You are not pregnant and (if in the moxidectin group) not planning to become pregnant in the next 3 months
- You are not currently hospitalized or too sick to get out of bed
- You are not taking part in another clinical trial at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different 3-drug combinations to treat lymphatic filariasis (a parasitic infection that can cause swelling and discomfort). If you live in a participating village, you will get one of these treatments and be monitored for how well it works.
This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.
This study tests a new medicine called emodepside to treat infections caused by intestinal worms like whipworm, hookworm, and roundworm. It may help people who have not been cured by standard treatments.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
Hear when a new Onchocerciasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.